The aim of my project is to identify Cathepsin S inhibitors using in silico models and in vitro through fluorescence-based enzyme assay, and tissue culture.
Atherosclerosis is a chronic inflammatory disease that significant contributions to incidents of CVDs such as heart failure, stroke, and hypertension. It is caused by a high accumulation of low-density lipoprotein (LDL) in the subendothelial with subsequent LDL oxidation into oxLDLs, and high blood pressure activates endothelial cells, promotes the expression of adhesion molecules, and facilitates the migration of monocytes into the aortic wall. Again, Cathepsin S which is found in the spleen, macrophages, and lymph may act like matrix metalloproteinase and releases adhesion molecules.
Research on animal models of atherosclerosis has shown that cathepsin S deficiency resulted in smaller atherosclerotic plaques and reduced disruption of elastic fiber sheets within the tunica media. For the project, I have proposed to use RAW264.7 and Primary Human Aortic Endothelial Cells (HAoEC) cells.